Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary / [electronic resource] :
Theresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies.
- Washington, D.C. : National Academies Press, 2009.
- 149 p. : ill.
Includes bibliographical references (p. 104-105).
Electronic reproduction.
Palo Alto, Calif. :
ebrary,
2013.
Available via World Wide Web.
Access may be limited to ebrary affiliated libraries.
Orphan drugs--Government policy--United States.
Pharmaceutical policy--United States.
Drugs--Design--United States.
Electronic books.
RA401.A3 / B74 2009eb
Includes bibliographical references (p. 104-105).
Electronic reproduction.
Palo Alto, Calif. :
ebrary,
2013.
Available via World Wide Web.
Access may be limited to ebrary affiliated libraries.
Orphan drugs--Government policy--United States.
Pharmaceutical policy--United States.
Drugs--Design--United States.
Electronic books.
RA401.A3 / B74 2009eb